Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is an increase over the number of companies cited in the previous quarter.
Of the four citations issued, the most common citation was 'Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed'.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Examinetics, Inc. | Devices | 10/05/2023 | Quality Audit/Reaudit - conducted |
Examinetics, Inc. | Devices | 10/05/2023 | Design validation - user needs and intended uses |
TriRx Shawnee, LLC | Drugs | 12/15/2023 | Procedures for sterile drug products |
TriRx Shawnee, LLC | Veterinary | 12/15/2023 | Procedures for sterile drug products |